Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2012 2
2014 3
2015 1
2017 3
2018 4
2019 2
2020 4
2021 7
2022 7
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Pretomanid-resistant tuberculosis.
Koehler N, Andres S, Merker M, Dreyer V, John A, Kuhns M, Krieger D, Choong E, Verougstraete N, Zur Wiesch PA, Wicha SG, König C, Kalsdorf B, Sanchez Carballo PM, Schaub D, Werngren J, Schön T, Peloquin CA, Schönfeld N, Verstraete AG, Decosterd LA, Aarnoutse R, Niemann S, Maurer FP, Lange C. Koehler N, et al. Among authors: konig c. J Infect. 2023 May;86(5):520-524. doi: 10.1016/j.jinf.2023.01.039. Epub 2023 Feb 2. J Infect. 2023. PMID: 36738862 No abstract available.
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, Hohn A, Weigand M, Michels G, Kluge S, Nierhaus A, Jarczak D, König C, Weismann D, Frey O, Witzke D, Müller C, Bauer M, Kiehntopf M, Neugebauer S, Lehmann T, Roberts JA, Pletz MW; TARGET Trial Investigators. Hagel S, et al. Among authors: konig c. Intensive Care Med. 2022 Mar;48(3):311-321. doi: 10.1007/s00134-021-06609-6. Epub 2022 Feb 1. Intensive Care Med. 2022. PMID: 35106617 Free PMC article. Clinical Trial.
The CD83 Molecule - An Important Immune Checkpoint.
Grosche L, Knippertz I, König C, Royzman D, Wild AB, Zinser E, Sticht H, Muller YA, Steinkasserer A, Lechmann M. Grosche L, et al. Among authors: konig c. Front Immunol. 2020 Apr 17;11:721. doi: 10.3389/fimmu.2020.00721. eCollection 2020. Front Immunol. 2020. PMID: 32362900 Free PMC article. Review.
Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.
Giannella M, Verardi S, Karas A, Abdel Hadi H, Dupont H, Soriano A, Santerre Henriksen A, Cooper A, Falcone M; ARES Study Group. Giannella M, et al. Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37496600 Free PMC article.
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses.
La Marca JE, Aubrey BJ, Yang B, Chang C, Wang Z, Kueh A, Tai L, Wilcox S, Milla L, Heinzel S, Vremec D, Whelan L, König C, Kaloni D, Voss AK, Strasser A, Diepstraten ST, Herold MJ, Kelly GL. La Marca JE, et al. Among authors: konig c. Cell Death Differ. 2024 Feb;31(2):150-158. doi: 10.1038/s41418-023-01249-3. Epub 2023 Dec 14. Cell Death Differ. 2024. PMID: 38097622 Free PMC article.
Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
Tesch F, Ehm F, Vivirito A, Wende D, Batram M, Loser F, Menzer S, Jacob J, Roessler M, Seifert M, Kind B, König C, Schulte C, Buschmann T, Hertle D, Ballesteros P, Baßler S, Bertele B, Bitterer T, Riederer C, Sobik F, Reitzle L, Scheidt-Nave C, Schmitt J. Tesch F, et al. Among authors: konig c. Clin Rheumatol. 2023 Oct;42(10):2905-2914. doi: 10.1007/s10067-023-06670-0. Epub 2023 Jun 19. Clin Rheumatol. 2023. PMID: 37335408 Free PMC article.
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis.
Köhler N, Karaköse H, Grobbel HP, Hillemann D, Andres S, König C, Kalsdorf B, Brehm TT, Böttcher L, Friesen I, Hoffmann H, Strelec D, Schaub D, Peloquin CA, Schmiedel S, Decosterd LA, Choong E, Wicha SG, Aarnoutse RE, Lange C, Sánchez Carballo PM. Köhler N, et al. Among authors: konig c. Pharmaceutics. 2023 Oct 27;15(11):2543. doi: 10.3390/pharmaceutics15112543. Pharmaceutics. 2023. PMID: 38004523 Free PMC article.
Soluble CD83 improves and accelerates wound healing by the induction of pro-resolving macrophages.
Royzman D, Peckert-Maier K, Stich L, König C, Wild AB, Tauchi M, Ostalecki C, Kiesewetter F, Seyferth S, Lee G, Eming SA, Fuchs M, Kunz M, Stürmer EK, Peters EMJ, Berking C, Zinser E, Steinkasserer A. Royzman D, et al. Among authors: konig c. Front Immunol. 2022 Sep 30;13:1012647. doi: 10.3389/fimmu.2022.1012647. eCollection 2022. Front Immunol. 2022. PMID: 36248909 Free PMC article.
44 results